louisiana semaglutide diarrhea class action FDA warns Ozempic and Wegovy maker over unreported GLP-1 side effects Lawsuit filed against makers of
Description
2025;39(2):e1534
Understanding Semaglutide: The Science Behind the Success Semaglutide is a GLP-1 receptor agonist that has received FDA approval specifically for long-term weight management in adults with obesity and those who have weight-related health conditions
Zheng X, Liang Y, Zhang C (2023) Ferroptosis regulated by hypoxia in cells
Is Retatrutide the Same as Ozempic
doi: 10.1016/B978-0-12-381517-0.00015-1
